N&O Index Card
Subject/Name: Burroughs Wellcome Company
Article(s) Referenced In:
- Burroughs Wellcome, NIH collide over AIDS treatment - Ja 5 91 8C
- Letter says Burroughs owes credit for drug - Ja 9 91 6C
- Burroughs Wellcome executive (Reckert) leaves - Fe 12 91 2D
- Drug shown to prevent herpes up to 3 years - Fe 13 91 10A
- Maker recalls Sudafed; 2 poison deaths linked to capsules - Mr 4 91 1
- Firm offers reward in Sudafed tampering case - Mr 8 91 6C
- Burroughs begins ads on its recall of Sudafed - Mr 14 91 7C
- Nader-backed group sues Burroughs; Complaint challenges AZT patent - Mr 20 91 6C
- Burroughs battling to keep rights to AZT patent - Ap 23 91 1D
- Sudafed maker turns to tablets; 12-hour capsule won't be back - Ap 27 91 1
- Burroughs Wellcome reports flat sales - My 3 91 6C
- Burroughs sues to block generic AZT - My 16 91 7C
- Report says FDA may help fight Burroughs Wellcome's lock on AZT - My 18 91 1
- (National Cancer) Institute might sue Burroughs (over AZT) - My 21 91 1D
- NIH won't go to court over AZT patent rights - My 29 91 6C
- Drug maker to ban smoking; Burroughs Wellcome plans gradual cutoff - Jn 26 91 7C
- Judge allows Burroughs to sell leftover Sudafed outside U.S. - Jn 29 91 6C
- Burroughs names marketing officer (Rothwell); Bristol-Myers transfer gets post - Jy 10 91 5C
- Barr Labs promised license for AZT; But issuance is tied to winning patent suit - Jy 18 91 7C
- Drug firm attacks wastes; Burroughs to spend $18 million at (Greenville) plant - Au 15 91 6C
- Burroughs weighs its prescription for giving - Se 8 91 1F
- Mice created to test drugs for HIV treatment - Se 9 91 1B
- Burroughs beefs up aid to AIDS patients; But $10 million plan draws fire - Se 11 91 9C
- AIDS research finds 2 drugs better than 1 - Se 27 91 5B
- Burroughs Wellcome gives museum $250,000 - Oc 10 91 2B
- Mich. hospital bars Burroughs salesmen; N.C. drug maker among 6 targeted - Oc 10 91 10C
- Burroughs Wellcome plans announcement on new drug - No 12 91 1D
- AIDS activists now cooperating with drug maker - No 13 91 12A
- FDA gives Burroughs Wellcome go-ahead on new AIDS therapy - No 13 91 1
- Zovirax recommended to treat chicken pox - No 13 91 9C
- Burroughs pledges $1.45 million to UNC-CH - De 13 91 6C
See a typo in our data? Let us know and we'll fix it.
Places you might find this article:
Search For This Topic
Help us correct this text for future researchers.
Type your transcription below – don't worry about formatting. Please include the line number you are correcting.
Thank you!